Robyn Tamblyn
Professor, Department of Medicine; Director, Division of Clinical Epidemiology
Dr. Tamblyn conducts research aimed at improving the safety and quality of health care. Her research program includes studies that:
- Identify modifiable determinants of adverse events and improved health outcomes (e.g. health professional competence, nurse staffing, drugs, timely access to complete patient information, early detection of emerging epidemics), and
- Developing and evaluating computer-enabled interventions to address these determinants (e.g. computerized decision-support, personal health record portals and self-management tools, automated surveillance systems).
The Canadian Foundation for Innovation, the Canadian Institutes of Health Research, the Canadian Patient Safety Institute, and the MUHC Research Institute fund her research. The computerized solutions her research group has developed have won the QUALCOMM quality award for public impact and the Bombardier Award for Innovation.
Tamblyn R, Winslade N, Lee TC, Motulsky A, Meguerditchian A, Bustillo M, Elsayed S, Buckeridge D, Couture I, Qian C, Moraga T, Huang A. (Oct 11 2017) Improving patient safety and efficiency of medication reconciliation through the development and adoption of a computer-assisted tool with automated electronic integration of population-based community drug data: the RightRx project. Journal of the American Medical Informatics Association. Vol. 25(5):482-495.
Tamblyn R, Winslade N, Qian CJ, Moraga T, Huang A (2017) What is in your wallet? A cluster randomized trial of the effects of showing comparative patient out-of-pocket costs on primary care prescribing for uncomplicated hypertension. Implementation Science. Vol. 13:7.
Tamblyn R, Girard N, Qian CJ, Hanley J (April 23 2018) Assessment of potential bias in research grant peer review in Canada. Canadian Medical Association Journal. Vol.190:E489-99.
Eguale T, Buckeridge D, Verma A, Winslade N, Benedetti A, Hanley J, Tamblyn R. (Jan 2016) The Association of Off-label Drug Use and Adverse Drug Events in an Adult Population. JAMA Internal Medicine. Vol. 176(1):55-63.
Tamblyn R, Girard N, Dixon WG, Haas JS, Bates DW, Sheppard T, Eguale T, Buckeridge D, Abrahamowicz M, Forster A. (Sept 2016) Pharmacosurveillance without borders: electronic health records in different countries can be used in estimating the risk of adverse events. Journal of Clinical Epidemiology. Vol. 77:101-111.